Conditions: Systemic Lupus Erythematosus (SLE); Lupus Nephritis (LN); Systemic Sclerosis (SSc); Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome (APS)
Interventions: Drug: YTS109 cell
Sponsors: China Immunotech (Beijing) Biotechnology Co., Ltd.; The First Affiliated Hospital of Anhui Medical University
Not yet recruiting Conditions: Systemic Lupus Erythematosus (SLE); Lupus Nephritis (LN); Systemic Sclerosis (SSc); Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome (APS)
Interventions: Drug: YTS109 cell
Sponsors: China Immunotech (Beijing) Biotechnology Co., Ltd.; The First Affiliated Hospital of Anhui Medical University
Not yet recruiting
